Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer-Reference-Cited by-同舟云学术

Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer

Published:2022-12 Issue: Volume:66 Page:145-156
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Aapro Matti,Cardoso Fatima,Curigliano Giuseppe,Eniu Alexandru,Gligorov Joseph,Harbeck Nadia,Mueller Andreas,Pagani Olivia,Paluch-Shimon Shani,Senkus Elzbieta,Thürlimann Beat,Zaman Khalil

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference107 articles.

1. International Agency for Research on Cancer. World Health Organization. International Agency for Research on Cancer. Globocan 2020. Breast. https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf. Accessed March 16, 2022.

2. European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer;Carioli;Ann Oncol,2021

3. Management of breast cancer during the COVID-19 pandemic: a stage- and subtype-specific approach;Sheng;JCO Oncol Pract,2020

4. Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US;Cronin;Cancer Invest,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Safety, Tolerability, and Immunogenicity of BP02 (Trastuzumab Biosimilar) Compared to EU- and US-Approved Trastuzumab in Healthy Adult Male Volunteers: A Phase 1, Randomized, Double-Blind Study;Oncology and Therapy;2024-07-07

2. Trastuzumab-Deruxtecan: Redefining HER2 as a Tumor Agnostic Biomarker;Targeted Oncology;2024-07-04

3. Case report: A promising neoadjuvant treatment option for individuals with locally advanced HER2-positive breast cancer involves the use of Pyrotinib Maleate in combination with Trastuzumab and Pertuzumab;Heliyon;2024-07

4. GRB2 is a BECN1 interacting protein that regulates autophagy;Cell Death & Disease;2024-01-05

5. Efficacy and Safety of Neoadjuvant Pyrotinib for Human Epidermal Receptor 2-Positive Breast Cancer: A Meta-Analysis;The Tohoku Journal of Experimental Medicine;2024